Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma
In this SOHO Insider podcast, host Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, spoke with Roberto Mina, MD, associate professor of hematology at Emory University, on news from the 2026 ASCO Annual Meeting.
The conversation highlighted a presentation by Dr. Roberto Mina regarding the pivotal phase 3 MajesTEC-9 trial evaluating teclistamab monotherapy for patients with relapsed/refractory multiple myeloma who were previously exposed to lenalidomide and anti-CD38 antibodies
Follow more news from ASCO here.
5 Jun 2026
Dr. Jeffery Matous presents ‘Managing access to novel agents in the community setting’
The third session of the Community Oncology Brown Bag Series, hosted by SOHO Insider, held on March 18, 2026, and featured guest speaker Jeffrey Matous, a member of the Colorado Blood Cancer Institute and clinical professor of medicine at the University of Colorado. Dr. Matous discussed “Managing access to novel agents in the community setting.”
This program is led by Loretta Nastoupil, MD, the SOHO Insider community oncology section editor.
To register for the series, go to https://soho.click/community-oncology-series
30 Apr 2026
Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer
In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from the 2026 Tandem Meetings, including updates on dual-targeted CAR T-cell results in CLL and interim phase 2 data on zamtocabtagene autoleucel (zamto-cel) in in transplant-ineligible patients with DLBCL.
Of dual-targeting CAR-T cell therapies, he said, “I think this is the next iteration in CAR. Zamtocabtagene is one of four 20/19 CARs under development and if you look at the data for all of them, they look to be highly efficacious, better than our standard CD19-CAR.”
Listen to more podcasts on sohoinsider.com.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Contact Society of Hematologic Oncology Insider news
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Society of Hematologic Oncology Insider news?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
